Skip to main content
. 2008 Sep;2(3):613–621. doi: 10.2147/opth.s3881

Figure 1.

Figure 1

Improvement in ocular surface disease index scores with travoprost BAK-free according to previous prostaglandin analog use. *p < 0.0001.